Medifocus Inc. is a Canada-based company that develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia (BPH). The Company owns two technology platforms with comprehensive United States and international patent protection: The Endo-thermotherapy Platform-a catheter-basis focused heat technology platform that utilizes natural body openings to deliver precise microwave thermotherapy to the diseased sites. The platform can potentially be used to treat cancers in prostate, rectum, cervix and esophagus. The Adaptive Phased Array (APA) Microwave Focusing Platform directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The Company’s APA 1000 Breast Cancer Treatment System, developed from the APA technology platform, is in pivotal Phase-III clinical trials.